Nautis is an AI-native Startup Operating System that combines planning, fundraising, finance, sales, team management, and utilities in one platform.

Who is Nautis built for?

Nautis is designed for startup founders, core teams, incubators, and investors who need structured visibility and fast execution.

How does Nautis help with fundraising?

Nautis includes pitch deck workflows, investor management, secure data rooms, cap table support, and readiness signals to improve fundraising execution.

Does Nautis include financial tracking?

Yes. Nautis includes financial planning, expense tracking, invoicing, and startup health metrics to monitor runway and performance.

Can incubators use Nautis for cohort management?

Yes. Incubators can standardize startup reporting, track progress, assess readiness, and generate structured ecosystem-level visibility.

Can investors use Nautis for diligence and monitoring?

Yes. Investors can review structured startup data, compare opportunities consistently, and track portfolio execution over time.

Break Trail Ventures

United States$100K – $500K chequesUpdated May 2026

Website LinkedIn X / Twitter Crunchbase

Led by a solo GP, an early institutional investor that uses a learn-first networking approach—deep founder/category diligence—with bi-regional Columbus–Boulder presence centered on consumer, fashion, health/wellness, and brand+tech SaaS/IoT Through targeted capital deployment, the fund plays an active role in the startup ecosystem.

Cheque size: $100K – $500K
Stages: Series A
Industries: Healthcare E-commerce Technology
Operating in: United States
How they invest: Not specified
Technologies: Not specified

Similar investors

Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.

AIN Ventures

United States

83% match

Seed-stage investor in dual-use deep tech (six verticals) with an invite-only U.S. Service Academy alumni syndicate that co-invests, sources, vets deals, presents post-investment support, and runs a veteran-led track. The firm continues to build its presence across the venture capital landscape.

Invests at Series A
Healthcare · Technology
Active in United States

Series AHealthcareTechnology

$500K – $1M

ARCH Venture Partners

United States

83% match

Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.

Invests at Series A
Healthcare · Technology
Active in United States

Series AHealthcareTechnology

Is dedicated to impactful businesses aiming to positively transform the world's food system.

Invests at Series A
Healthcare · E-commerce
Active in United States

Series AAgricultureHealthcare

Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.

Invests at Series A
Healthcare · Technology
Active in United States

Series AFinanceHealthcare

Builds AI companies from inception alongside recruited CEOs, acting as an AI R&D studio that sources ideas with large corporates to deliver agentic-AI ventures with built-in customers and traction. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.

Invests at Series A
Healthcare · Technology
Active in United States

Series ATechnologyHealthcare

Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.